LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE HODGKIN LYMPHOMA (HL): UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD7, HD8, HD10 AND HD11 TRIALS

被引：0
|
作者：
Broeckelmann, P. J.
Goergen, H.
Pluetschow, A.
Kreissl, S.
Buerkle, C.
Borchmann, S.
Fuchs, M.
Borchmann, P.
Engert, A.
机构：
[1] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany
[2] Univ Hosp Cologne, German Hodgkin Study Grp GHSG, Cologne, Germany
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S106
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [1] Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials
    Sasse, Stephanie
    Broeckelmann, Paul J.
    Goergen, Helen
    Pluetschow, Annette
    Mueller, Horst
    Kreissl, Stefanie
    Buerkle, Carolin
    Borchmann, Sven
    Fuchs, Michael
    Borchmann, Peter
    Diehl, Volker
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (18) : 1999 - +
  • [2] LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE FAVORABLE HODGKIN LYMPHOMA: UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD7 AND HD10 TRIAL
    Sasse, S.
    Broeckelmann, P. J.
    Goergen, H.
    Pluetschow, A.
    Mueller, H.
    Kreissl, S.
    Buerkle, C.
    Borchmann, S.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    HAEMATOLOGICA, 2016, 101 : 12 - 12
  • [3] LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA: UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD8 AND HD11 TRIAL
    Sasse, S.
    Broeckelmann, P. J.
    Goergen, H.
    Pluetschow, A.
    Mueller, H.
    Kreissl, S.
    Buerkle, C.
    Borchmann, S.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    HAEMATOLOGICA, 2016, 101 : 13 - 14
  • [4] ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials
    Boell, Boris
    Goergen, Helen
    Fuchs, Michael
    Pluetschow, Annette
    Eich, Hans Theodor
    Bargetzi, Mario J.
    Weidmann, Eckhart
    Junghanss, Christian
    Greil, Richard
    Scherpe, Alexander
    Schmalz, Oliver
    Eichenauer, Dennis A.
    von Tresckow, Bastian
    Rothe, Achim
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) : 1522 - 1529
  • [5] Long-term outcome of patients with early-stage nodular lymphocyte-predominant hodgkin lymphoma (NLPHL) treated within the randomized HD7, HD10 and HD13 trials: An analysis from the German Hodgkin Study Group (GHSG)
    Eichenauer, D. A.
    Pluetschow, A.
    Fuchs, M.
    von Tresckow, B.
    Borchmann, P.
    Engert, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 142 - 142
  • [6] Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials
    Boell, Boris
    Goergen, Helen
    Behringer, Karolin
    Broeckelmann, Paul J.
    Hitz, Felicitas
    Kerkhoff, Andrea
    Greil, Richard
    von Tresckow, Bastian
    Eichenauer, Dennis A.
    Buerkle, Carolin
    Borchmann, Sven
    Fuchs, Michael
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2016, 127 (18) : 2189 - 2192
  • [7] Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Fuchs, Michael
    Sasse, Stephanie
    Baues, Christian
    Boell, Boris
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 698 - +
  • [8] Feasibility and Efficacy of ABVD In Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11)
    Boll, Boris
    Gorgen, Helen
    Fuchs, Michael
    von Tresckow, Bastian
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2010, 116 (21) : 186 - 187
  • [9] FEASIBILITY AND EFFICACY OF ABVD IN ELDERLY HODGKIN LYMPHOMA PATIENTS: ANALYSIS OF TWO RANDOMIZED PROSPECTIVE MULTICENTER TRIALS OF THE GERMAN HODGKIN STUDY GROUP (HD10 AND HD11)
    Boell, B.
    Goergen, H.
    Fuchs, M.
    von Tresckow, B.
    Engert, A.
    Borchmann, P.
    HAEMATOLOGICA, 2010, 95 : S39 - S39
  • [10] Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials
    Broeckelmann, Paul J.
    Goergen, Helen
    Kohnhorst, Charlotte
    Von Tresckow, Bastian
    Moccia, Alden
    Markova, Jana
    Meissner, Julia
    Kerkhoff, Andrea
    Ludwig, Wolf-Dieter
    Fuchs, Michael
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (13) : 1444 - +
12345